Leqin Xu
- Molecular Biology
- Oncology top 10%
- Cancer Research
- Pharmacology top 5%
- Rheumatology top 10%
- Topics
- Bone Tumor Diagnosis and Treatments (7 papers)Sarcoma Diagnosis and Treatment (6 papers)Pluripotent Stem Cells Research (4 papers)
- Partner nations
- ChinaUnited StatesAustria
In The Last Decade
Leqin Xu
23 papers receiving 872 citations
Peers
Comparison fields: 5 of 89
- Molecular Biology 557
- Oncology 237
- Cancer Research 140
- Pharmacology 136
- Rheumatology 131
Countries citing papers authored by Leqin Xu
This map shows the geographic impact of Leqin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leqin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leqin Xu more than expected).
Fields of papers citing papers by Leqin Xu
This network shows the impact of papers produced by Leqin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leqin Xu. The network helps show where Leqin Xu may publish in the future.
Co-authorship network of co-authors of Leqin Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Leqin Xu. A scholar is included among the top collaborators of Leqin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leqin Xu. Leqin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 33 | |
| 5 | 108 | |
| 6 | 26 | |
| 7 | 16 | |
| 8 | 7 | |
| 9 | 12 | |
| 10 | 277 | |
| 11 | 3 | |
| 12 | [OVER EXPRESSION OF Mash-1 GENE IN PROMOTING DIFFERENTIATION OF MOUSE EMBRYONIC STEM CELLS INTO NEURAL CELLS]. | 1 |
| 13 | 9 | |
| 14 | 10 | |
| 15 | 13 | |
| 16 | 1 | |
| 17 | 3 | |
| 18 | 72 | |
| 19 | 20 | |
| 20 | 183 |
About Leqin Xu
Leqin Xu is a scholar working on Rheumatology, Developmental Neuroscience and Oral Surgery, having authored 25 papers that have together received 885 indexed citations. Recurring topics across this work include Bone Tumor Diagnosis and Treatments (7 papers), Sarcoma Diagnosis and Treatment (6 papers) and Pluripotent Stem Cells Research (4 papers). The work is most often cited by research in Pharmacology (136 citations), Orthopedics and Sports Medicine (92 citations) and Cancer Research (140 citations). Leqin Xu has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Minghua Ma, Hua Nian, Jianru Xiao, Ruijuan Zhou, Yu Wen, Xuemei Chen, Junpeng Chen, Jian Luo, Mingyao Liu and Zhengfeng Yang. Their work appears in journals such as Nature Medicine, Free Radical Biology and Medicine and Acta Biomaterialia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.